| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -4.8e-05 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.00012 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |